RNCOS, a leading market research firm, has said in its report "China Healthcare Sector Analysis" that the healthcare expenditure in China is anticipated to grow at a CAGR of more than 18% during 2010-2012. Strong demand for healthcare services in rural areas will be the major driving factor for the prospective increase in healthcare spending.
The report also reveals that the number of specialized hospitals will increase in the country on account of the government decision to open the sector to private investment. Besides, the number of primary healthcare institutions will rapidly escalate to meet the soaring demand for quality primary healthcare services.
With the improvement of primary healthcare services, the scenario of key industry segments has substantially changed. For instance - the share of western drugs and devices in the Chinese healthcare market has significantly expanded and boosted the investments by foreign players. These players are setting up their own manufacturing units in order to take advantage of low cost manufacturing capability of the country.
The report is an outcome of extensive research and detailed study of the Chinese healthcare industry. In the report, all the important performance indicators have been thoroughly discussed. It also features forecast for each segment (healthcare services, pharmaceutical and medical devices) of the healthcare industry to provide better understanding of the sector. The pharmaceutical segment gives a brief overview of western and traditional drugs, imported drugs, key therapy areas and leading players. Similarly, the medical devices segment contains information about the market segmentation, import & export and key players.
"China Healthcare Sector Analysis" analyzes the trend of macroeconomic factors critical for the growth of healthcare sector. It has also identified the key players in the market which will give information about the competitive landscape. Additionally, the report sheds light on the emerging industry trends (like health insurance, health IT market, telemedicine and medical tourism) which are expected to decide the future of the Chinese healthcare sector.
For more information visit: http://www.rncos.com/Report/IM121.htm |
